Cantargia AB (publ) (STO:CANTA)
1.806
+0.016 (0.89%)
Sep 2, 2026, 5:29 PM CET
Cantargia AB Revenue
Cantargia AB had revenue of 95.00K SEK in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to 317.31M. In the year 2025, Cantargia AB had annual revenue of 316.70M.
Revenue (ttm)
317.31M
Revenue Growth
n/a
P/S Ratio
1.42
Revenue / Employee
14.42M
Employees
22
Market Cap
448.99M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 316.70M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sprint Bioscience AB | 138.95M |
| AlzeCure Pharma AB | 97.33M |
| Oncopeptides AB | 95.15M |
| IRLAB Therapeutics AB | 79.33M |
| Intervacc AB | 18.11M |
| Corline Biomedical AB | 11.85M |
| Xspray Pharma AB | 2.47M |
| FluoGuide | 404.33K |
Cantargia AB News
- 14 days ago - Cantargia AB Earnings Call Transcript: Q2 2026 - Transcripts
- 14 days ago - Cantargia AB Quarterly report: Q2 2026 - Filings
- 14 days ago - Cantargia AB Slides: Q2 2026 - Filings
- 15 days ago - Cantargia AB (OSTO:CANTA) Q2 2026: Everything You Need To Know Ahead Of Earnings - GuruFocus
- 15 days ago - Cantargia AB Slides: Corporate presentation - Filings
- 2 months ago - Cantargia AB Transcript: KOL event - Transcripts
- 2 months ago - Cantargia AB Press release: KOL event - Filings
- 3 months ago - Cantargia AB Transcript: Investor update - Transcripts